Arlington, Virginia, 8 April, 2026 — Viscadia, a premier global forecasting firm serving the life sciences industry, today announced that Douglas “Doug” Willson, Ph.D., has stepped into the role of Chief Methodologist, Integrated Insights.
This appointment reflects Viscadia’s continued investment in advancing how market research and analytics are designed, connected, and applied to drive more accurate forecasts and stronger business decisions across pharmaceutical and biotechnology organizations.
In his role as Chief Methodologist, Doug will define and lead the methodological foundation of Viscadia’s Integrated Insights approach. He will focus on ensuring that market research and analytics are not conducted in isolation but are intentionally structured to generate the right inputs for forecasting models, commercial strategy, and long-range planning.
Satish K. Kauta, CEO, sees Doug’s appointment as central to that mission: “With Doug leading this new function, Viscadia is excited to deepen our commitment to providing our clients a fully integrated approach to forecasting.”
As life sciences organizations navigate increasing complexity across product launches, competitive dynamics, and expanding data ecosystems, the ability to translate insights into decision-ready inputs has become critical. Doug’s role is central to helping Viscadia’s clients bridge that gap by connecting market research, analytics, and forecasting in a way that is structured, aligned, and actionable.
Doug brings more than 30 years of experience in quantitative market research and analytics within the life sciences industry. He specializes in demand studies, conjoint and choice modeling, early-stage commercial assessments, and market sizing, with a strong track record of aligning research design to real-world business decisions.
Throughout his career, Doug has partnered with global pharmaceutical and biotechnology companies across key therapeutic areas including oncology, autoimmune conditions, cardiovascular and diabetes, and rare diseases. Prior to joining Viscadia, he held leadership roles at Ipsos Healthcare, ZS Associates, Bell Falla, and Cello Health Advantage, where he led complex engagements at the intersection of market research, analytics, and commercial strategy.
Sharing his enthusiasm for the role, Doug states, “I am thrilled to step into the Chief Methodologist role – looking forward to continuing to work with the talented Viscadia team who truly emphasize the role of integrated insights in driving business decisions.”
Doug holds a Ph.D. in Economics from the University of Pennsylvania, along with a Master’s degree in Economics and a Bachelor of Commerce in Finance from the University of Toronto.
Doug’s appointment marks an important step in Viscadia’s continued evolution, advancing how integrated insights are applied to address increasingly complex forecasting and commercial challenges across the life sciences industry.
About Viscadia
Viscadia is a premier global forecasting firm that empowers the life sciences industry with clarity and confidence through forecasting. We conduct market research that informs and drives the forecast, design and build custom models and platforms that create the forecast and provide ongoing cycle support to manage the forecasting process. To learn more, visit www.viscadia.com.
